Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient Oral vs Inpatient Intravenous Therapy for Acute Non-severe Osteomyelitis in Children
2024-516744-26-00Phase 2Authorised
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2024
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cefazolin, cloxacillin, amoxicillin and clavulanic acid in osteomyelitis (OM) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Complete recovery without relapse at 6 months. Planned start Nov 2024; status: authorised.
02
Drugs
cefazolincloxacillinamoxicillinclavulanic acid
03
Conditions
osteomyelitis (OM)
Beyond the preview
Go deeper on 2024-516744-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516744-26-00.